Publication:
In vitro activity of clinically implemented β-lactams against Aerococcus urinae: presence of non-susceptible isolates in Switzerland.

cris.virtual.author-orcid0000-0002-7870-912X
cris.virtual.author-orcid0000-0002-1375-3146
cris.virtual.author-orcid0000-0003-3186-5421
cris.virtualsource.author-orcid1074de5f-c046-4bd4-a277-37d302129613
cris.virtualsource.author-orciddee449c4-635d-47de-8c95-84c28abe0abb
cris.virtualsource.author-orcid007a455c-6f7d-4906-a0db-2a2c547fca83
cris.virtualsource.author-orcid174f1323-7162-433b-b035-614cbab79f1c
cris.virtualsource.author-orcid4b2586ba-f6ae-4b79-b718-7dfdc6b7825e
datacite.rightsrestricted
dc.contributor.authorLupo, Agnese
dc.contributor.authorGuilarte, Yuvia N
dc.contributor.authorDroz, Sara Christine
dc.contributor.authorHirzel, Cédric
dc.contributor.authorFurrer, Hansjakob
dc.contributor.authorEndimiani, Andrea
dc.date.accessioned2024-10-23T17:08:47Z
dc.date.available2024-10-23T17:08:47Z
dc.date.issued2014-10
dc.description.abstractWe analyzed the in vitro susceptibility to several ?-lactams and vancomycin of 80 Aerococcus urinae isolates col- lected during 2011-2012 in Switzerland. MICs were determined by Etest (bioMérieux) on Müller-Hinton agar with 5% sheep blood and interpreted according to the CLSI and EUCAST criteria set for viridans streptococci. MIC50/90 for penicillin, amoxicillin, ceftriaxone and vancomycin were 0.016/0.064 mg/l, 0.032/0.064 mg/l, 0.125/0.5 mg/l and 0.38/0.5 mg/l, respectively. Three (3.8%) isolates were resistant to ceftriaxone regardless of the criteria used (MICs ?2 mg/l); one of them was also non-susceptible to penicillin (MIC of 0.25 mg/l) according to CLSI. ?-lactam resis- tance in A. urinae is a concern and suggests that more studies are needed to determine the molecular mechanisms of such resistance.
dc.description.numberOfPages4
dc.description.sponsorshipInstitut für Infektionskrankheiten
dc.description.sponsorshipUniversitätsklinik für Infektiologie
dc.identifier.doi10.7892/boris.60166
dc.identifier.pmid25387295
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/127493
dc.language.isoen
dc.publisherEdizioni Medico Scientifiche
dc.relation.ispartofThe new microbiologica
dc.relation.issn1121-7138
dc.relation.organizationClinic of Infectiology
dc.relation.organizationInstitute for Infectious Diseases
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc500 - Science::570 - Life sciences; biology
dc.titleIn vitro activity of clinically implemented β-lactams against Aerococcus urinae: presence of non-susceptible isolates in Switzerland.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage566
oaire.citation.issue4
oaire.citation.startPage563
oaire.citation.volume37
oairecerif.author.affiliationInstitut für Infektionskrankheiten
oairecerif.author.affiliationInstitut für Infektionskrankheiten
oairecerif.author.affiliationUniversitätsklinik für Infektiologie
oairecerif.author.affiliationUniversitätsklinik für Infektiologie
oairecerif.author.affiliationInstitut für Infektionskrankheiten
oairecerif.identifier.urlhttp://www.newmicrobiologica.org/PUB/allegati_pdf/2014/4/563.pdf
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId60166
unibe.journal.abbrevTitleNew Microbiol.
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
563.pdf
Size:
131.13 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections